Xiaogang Wang
- Molecular Biology top 5%
- Cancer Research top 2%
- Genetics top 10%
- Biomedical Engineering
- Oncology
- Topics
- MicroRNA in disease regulation (17 papers)Circular RNAs in diseases (11 papers)Cancer-related molecular mechanisms research (9 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaogang Wang
51 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Molecular Biology 2.1k
- Cancer Research 827
- Genetics 336
- Biomedical Engineering 222
- Oncology 221
Countries citing papers authored by Xiaogang Wang
This map shows the geographic impact of Xiaogang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaogang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaogang Wang more than expected).
Fields of papers citing papers by Xiaogang Wang
This network shows the impact of papers produced by Xiaogang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaogang Wang. The network helps show where Xiaogang Wang may publish in the future.
Co-authorship network of co-authors of Xiaogang Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaogang Wang. A scholar is included among the top collaborators of Xiaogang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaogang Wang. Xiaogang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 11 | |
| 4 | Multiscale architecture design of 3D printed biodegradable Zn-based porous scaffolds for immunomodulatory osteogenesisbreakdown → | 53 |
| 5 | 0 | |
| 6 | 9 | |
| 7 | 4 | |
| 8 | 9 | |
| 9 | 42 | |
| 10 | 31 | |
| 11 | 16 | |
| 12 | 14 | |
| 13 | 13 | |
| 14 | 55 | |
| 15 | 19 | |
| 16 | 9 | |
| 17 | 47 | |
| 18 | 31 | |
| 19 | ERCC1 and BRCA1 expressions in advanced non-small cell lung cancer and their relationship with cisplatin resistance. | 4 |
| 20 | Studies on Callus Induction of Camptotheca Acuminata Decaisne and Camptothecin Production | 1 |
About Xiaogang Wang
Xiaogang Wang is a scholar working on Cancer Research, Molecular Biology and Aging, having authored 53 papers that have together received 2.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), Circular RNAs in diseases (11 papers) and Cancer-related molecular mechanisms research (9 papers). The work is most often cited by research in Cancer Research (827 citations), Aging (86 citations) and Business and International Management (91 citations). Xiaogang Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shihua Yang, Qunshan Huang, Xiaohui Zhang, Louis Y. Tee, Jia Xiao, Yao Sun, Mingxiang Cai, Yayu Wang, Jiafan Liu and Xiaojia Chen. Their work appears in journals such as Circulation, Nature Communications and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.